Central nervous system involvement by multiple myeloma is extremely rare and is diagnosed in less than 1% of cases. Differential diagnosis includes lymphomas, metastases, sarcomas, osteochondromas, hemangiopericytomas or meningiomas. We report a 46-year-old female with a history of multiple myeloma in apparent remission after autologous bone marrow transplantation, who consulted for a palpable mass in the frontal region associated with holocranial headache and decreased visual acuity of two months of evolution with imaging studies compatible with olfactory sulcus meningioma. A craniotomy and total resection of the lesion by bicoronal approach was performed and histological sections showed a neoplastic proliferation consisting of cells with a spherical nucleus and lateralized eosinophilic cytoplasm. Lesion compatible with involvement of the central nervous system by multiple myeloma. This case highlights the diagnostic challenge due to radiologic similarity with other tumours, especially meningiomas, and emphasizes including myeloma in differential diagnoses.
Most cases of sciatica are caused by compression of lumbar nerve roots, although some originate from extraradicular structures, such as in ischiofemoral impingement syndrome. We present the case of a 64-year-old man with a 10-year history of right-sided sciatic pain occurring only while seated. He underwent several lumbar surgeries for spinal stenosis (L4-L5, then L3-L4, and later L5-S1 with fusion to S1), as well as multiple infiltrations and pulsed radiofrequency, without improvement. Neurophysiological and imaging studies showed no significant compression, except for oedema at the ischial insertion of the quadratus femoris muscle. A diagnostic local anaesthetic infiltration temporarily resolved the pain, confirming ischiofemoral impingement syndrome. He was treated with osteotomy of the lesser trochanter, achieving complete pain resolution and functional recovery. This case highlights the importance of considering extraradicular causes in patients with persistent sciatic pain after spinal surgery.
The experimental laboratory has been of paramount importance in the development and evolution of neurosurgery. In that research environment, many neurosurgical techniques were designed and the classics approaches to different regions of the brain were refined, until turning neurological surgery into atraumatic procedure, fulfilling one of the founding axioms of this speciality, that of delicate treatment on brain tissue, advocated by Harvey Cushing and later optimized by Professor Gazy Yasargil. The scenarios, their main characters, and the contributions they made to the development and progress of neurosurgery have all been analyzed in this article from a historical standpoint.
Pituitary metastases from renal cell carcinoma (PM-RCC) are rare, with an unfavorable prognosis and survival ranging from 6 to 22 months. The objectives of this study were (1) to present a case of a 61-year-old male who achieved a 44-month survival, and (2) to analyze the literature focusing on survival and worldwide distribution. The reported case achieved one of the longest survivals documented after multimodal treatment including surgery, radiotherapy, and targeted therapy. The systematic review showed that PM-RCC predominantly affects males (73.7%) and has a mean survival of 10.9 months, lower than that reported for other pituitary metastases (median 16.5 months). Metastasis was initially suspected in only 13.1% of cases, and surgery was the most common treatment (84%), with wide variation in adjuvant therapy use. Most cases originated from high-income countries, with very limited or no representation from some regions. Relevant characteristics and prognostic factors are discussed.
Background and aim: There is no consensus regarding the best timing of vertebral augmentation (VA) procedures for the treatment of osteoporotic thoracolumbar fractures. This study aims to determine if early VA (performed during the first 2 weeks of evolution) show an advantage over delayed surgery in terms of efficacy and safety outcomes, and to evaluate the role of different modifiable therapeutic variables on the same outcomes.
Material and methods: Single-center retrospective study including all patients aged >50 years who underwent VA for thoracolumbar osteoporotic fracture from 2010 to 2023. Patients with two events in less than 3 months or incomplete follow-up were excluded. Pain relief, fracture progression and cement extravasation were assessed with regression analyses.
Results: One hundred fifty-four procedures were analyzed, with no significant difference in pain relief according to the timing of surgery. Early VA (1-14 days after symptoms onset) was associated with higher risk of fracture progression compared to intermediate (15-60 days; OR 15.2, p=0.001) and delayed (>60 days; OR 16.2, p=0.013) procedures; higher risk of cement leakage into the disc or vascular space (OR 3.2, p=0.025); but lower risk of spinal canal cement leakage (OR 0.16, p=0.027). No differences were observed between vertebroplasty and kyphoplasty.
Discussion: Early VA showed equivalent but earlier effect on pain relief and reduced risk of spinal canal leakage when compared with delayed procedures, despite a non-clinically significant increased risk of fracture progression and cement leakage into the disc or drainage vessels. Thus, it was identified as the most effective strategy for balancing analgesic efficacy and procedural safety.
Background: Since gliomas have no cure, the quality of life (QoL) reported by patients assumes utmost importance in the therapeutic strategy. However, few studies have provided longitudinal data about how surgical resection impacts QoL as reported by patients, and even fewer have included preoperative assessments. The aim of this pilot study was to assess how glioma patients' QoL changes in the early postoperative period of glioma resection, at 1 month and 6 months, compared to preoperative.
Methods: Patients undergoing surgical resection of low-grade glioma (LGG) or high-grade glioma (HGG) were prospectively included from January 2022 to December 2022. To analyze patient-reported QoL we used EORTC QLQ-C30 and BN20 questionnaires applied preoperatively and at 1 and 6 months after surgery.
Results: We evaluated 34 patients (LGG-9; HGG-25). There were no differences in QoL at all evaluation time points between LGG and HGG groups. Within the LGG patients, QoL scores remained stable throughout 1- and 6-month evaluations. In patients with HGG, when compared to baseline, there were no meaningful variations in QoL at 1 month, but a clinically and statistically significant improvement (p=0.035) was found at 6 months. Total resection was associated with improved QoL in HGG patients at 6 months (p=0.025). At individual level, considering a minimum clinically significant value of 10, most HGG patients improved their QoL, while most LGG patients remained stable. Regarding subdomain analysis, a clinically and statistically significant improvement in future uncertainty was found in both LGG (p=0.042) and HGG (p=0.024) patients at 6 months.
Conclusions: Contrarily to previous studies that revealed a deterioration in HGG patients at 6 months, our preliminary data suggest an improvement in the QoL of these patients at 6 months. Additionally, total resection seems to be beneficial, as it was not associated with QoL deterioration, and can even improve QoL.

